$7.1M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Howe Jill AnnNov 26, 2024Buy15,000$0.59$8,900
Samuel George A. IIINov 26, 2024Buy15,000$0.6$9,000
Mulroy Michael H.Nov 22, 2024Buy40,000$0.566$23,000
Culley Brian MNov 21, 2024Buy40,000$0.6$24,000
Howe Jill AnnAug 16, 2024Buy10,500$0.89$9,300
Culley Brian MMay 24, 2024Buy10,000$1.05$11,000
BROADWOOD PARTNERS, L.P.Feb 6, 2024Buy6,730,770$1.04$7M
Jayasuriya AnulaDec 29, 2023Buy10,000$1.09$11,000

What's the latest insider transaction for Lineage Cell Therapeutics?

The most recent insider transaction for Lineage Cell Therapeutics was conducted by Howe Jill Ann, who sold 15,000 shares on November 26, 2024 at a price of $0.59 per share.

Which insider bought the most LCTX stock over the last two years?

BROADWOOD PARTNERS, L.P. has bought the most LCTX stock in the last 2 years, with a total value of $7M.

What is the total value of insider transactions for Lineage Cell Therapeutics (LCTX) in the last 2 years?

According to our estimates, the total value of insider transactions for Lineage Cell Therapeutics in the last 2 years is positive, amounting to $7.1M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.

How do insider transactions over the last 2 years reflect on Lineage Cell Therapeutics' market confidence?

Over the last 2 years, insider transactions for Lineage Cell Therapeutics have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.